Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq slides to near one-month low as AI rout deepens
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent oil slips as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
| Compugen Ltd (NASDAQ: CGEN) | Delayed: 2.11 +0.11 (5.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.00 | 52 Week High | $7.79 | |||
| Open | $2.02 | 52 Week Low | $4.32 | |||
| Day High | $2.13 | P/E | N/A | |||
| Day Low | $2.02 | EPS | $-0.36 | |||
| Volume | 110,197 | |||||
| Compugen Ltd (NASDAQ: CGEN) | Delayed: 2.11 +0.11 (5.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.00 | 52 Week High | $7.79 | |||
| Open | $2.02 | 52 Week Low | $4.32 | |||
| Day High | $2.13 | P/E | N/A | |||
| Day Low | $2.02 | EPS | $-0.36 | |||
| Volume | 110,197 | |||||
